Autor:	Maria Loushin, Zachary Gostout, Dacian Bonta, Patricia Zawisny, Giuseppe Del Priore
Rok vydání:	2018
Předmět:	Oncology Cancer Research medicine.medical_specialty business.industry Immune checkpoint inhibitors Internal medicine Medicine Response criteria business
Zdroj:	Journal of Clinical Oncology. 36:e14528-e14528
ISSN:	1527-7755 0732-183X
DOI:	10.1200/jco.2018.36.15_suppl.e14528
Popis:	e14528Background: Recent examples, such as iRECIST for checkpoint inhibitors, have demonstrated that response criteria other than RECIST 1.1 may be more appropriate for some therapeutic mechanisms....
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::750c0e41462a24c29366279481147fbf https://doi.org/10.1200/jco.2018.36.15_suppl.e14528 Zobrazit plný text záznamu